BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
41 auth. J. Liu, S. van Sommeren, Hailiang Huang, S. Ng, R. Alberts, A. Takahashi, S. Ripke, James C. Lee, L. Jostins, T. Shah, S. Abedian, J. Cheon, Judy H. Cho, N. Daryani, L. Franke, ... Y. Fuyuno, A. Hart, R. Juyal, G. Juyal, W. Kim, A. Morris, H. Poustchi, W. Newman, V. Midha, T. Orchard, H. Vahedi, A. Sood, J. Sung, R. Malekzadeh, H. Westra, K. Yamazaki, Suk-Kyun Yang, J. Barrett, A. Franke, B. Alizadeh, M. Parkes, T. B K, M. Daly, M. Kubo, C. Anderson, R. Weersma
11 2015
11
🐜
🐬 Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study.
Maryam Samsamikor, N. Daryani, P. R. Asl, A. Hekmatdoost
7 2015
7
🐬
🐬 Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study.
M. Samsamikor, N. Daryani, P. R. Asl, A. Hekmatdoost
6 2016
6
🐬
🐬 Alterations in Antioxidant Power and Levels of Epidermal Growth Factor and Nitric Oxide in Saliva of Patients with Inflammatory Bowel Diseases
Golshid Jahanshahi, Vian Motavasel, A. Rezaie, A. Hashtroudi, N. Daryani, M. Abdollahi
6 2004
6
🐬
🐬 Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis
A. Moayyeri, N. Daryani, H. Bahrami, B. Haghpanah, Atoosa Nayyer-Habibi, M. Sadatsafavi
5 2005
5
🐬
🐜 The Antimicrobial Effects and Metabolomic Footprinting of Carboxyl-Capped Bismuth Nanoparticles Against Helicobacter pylori
8 auth. P. Nazari, R. Dowlatabadi-Bazaz, M. Mofid, M. Pourmand, N. Daryani, M. Faramarzi, ... Z. Sepehrizadeh, A. Shahverdi
5 2013
5
🐜
🐜 Study on the Correlations among Disease Activity Index and Salivary Transforming Growth Factor‐β1 and Nitric Oxide in Ulcerative Colitis Patients
8 auth. A. Rezaie, S. Khalaj, Maryam Shabihkhani, S. Nikfar, M. J. Zamani, A. Mohammadirad, ... N. Daryani, M. Abdollahi
5 2007
5
🐜
🐜 Evaluation of a New Antigen for Diagnosis of Helicobacter pylori Infection in Stool of Adult and Children
13 auth. B. Pourakbari, A. Mirsalehian, P. Maleknejad, S. Mamishi, H. Azhdarkosh, N. Daryani, M. Najafi, B. Kazemi, M. Paknejad, S. Mahmoudi, ... M. Bandehpour, M. Ghazi, A. Salavati
5 2011
5
🐜
🐬 Assessing the role of the RND efflux pump in metronidazole resistance of Helicobacter pylori by RT-PCR assay.
J. Mehrabadi, M. Sirous, N. Daryani, S. Eshraghi, Bahram Akbari, M. Shirazi
4 2011
4
🐬
🐒 Does the inflammatory potential of diet affect disease activity in patients with inflammatory bowel disease?
7 auth. P. Mirmiran, N. Moslehi, Nava Morshedzadeh, N. Shivappa, J. HΓ©bert, F. Farsi, ... N. Daryani
4 2019
4
🐒
🐜 A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software
11 auth. F. Firouzi, Marjan Rashidi, S. Hashemi, M. Kangavari, A. Bahari, N. Daryani, ... M. Emam, N. Naderi, H. Shalmani, Alma Farnood, M. Zali
4 2007
4
🐜